"Atopia" Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sladek, Krzysztof
SPARTA, NCT01983241 / 2013-001870-38: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

Active, not recruiting
3
345
Europe, Canada, US, RoW
Alpha-1 MP, Prolastin-C, 0.9% Sodium Chloride for Injection, USP, Saline
Grifols Therapeutics LLC
Pulmonary Emphysema in Alpha-1 PI Deficiency
08/26
01/27
ELEVAATE, NCT05856331: Study of INBRX-101 Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Recruiting
2
90
Europe, US, RoW
INBRX-101, Zemaira
Sanofi
Alpha 1-Antitrypsin Deficiency, Emphysema
06/25
09/25
NCT03870828: Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study

Not yet recruiting
N/A
210
Europe
Bronchoalveolar lavage and taking bronchial mucosa samples, 6minute walk test, 6MWT, Arterial blood gas, ABG, Blood drawing
Medical University of Silesia
Interstitial Lung Disease, Interstitial Pneumonia, Interstitial Fibrosis, Autoimmune Diseases
02/20
12/25

Download Options